Published in Dig Dis Sci on June 04, 2012
Distinctive aspects of peptic ulcer disease, Dieulafoy's lesion, and Mallory-Weiss syndrome in patients with advanced alcoholic liver disease or cirrhosis. World J Gastroenterol (2016) 1.02
Endoscopic treatment of esophageal varices in patients with liver cirrhosis. World J Gastroenterol (2014) 0.84
Cirrhosis and gastrointestinal bleeding. Dig Dis Sci (2012) 0.75
Capsule Endoscopy for Portal Hypertensive Enteropathy. Gastroenterol Res Pract (2015) 0.75
Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol (2010) 5.78
The course of patients after variceal hemorrhage. Gastroenterology (1981) 3.33
The prevalence of hemorrhoids and chronic constipation. An epidemiologic study. Gastroenterology (1990) 3.22
Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology (2003) 3.19
Helicobacter pylori. Am J Gastroenterol (1994) 2.88
Mucosal abnormalities of the small bowel in patients with cirrhosis and portal hypertension: a capsule endoscopy study. Gastrointest Endosc (2005) 2.82
Treatment of gastric antral vascular ectasia (watermelon stomach) with endoscopic band ligation. Gastrointest Endosc (2008) 2.37
Mallory-Weiss tears occurring during endoscopy: a report of seven cases. Endoscopy (1992) 2.24
Changing trends in acute upper-GI bleeding: a population-based study. Gastrointest Endosc (2009) 2.08
Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis. Gastroenterology (1995) 2.04
Dieulafoy's lesion: current trends in diagnosis and management. Ann R Coll Surg Engl (2010) 2.03
The pathogenesis of Dieulafoy's gastric erosion. Am J Gastroenterol (1984) 1.97
Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut (1999) 1.91
Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet (1991) 1.88
A retrospective study of the application on double-balloon enteroscopy in 378 patients with suspected small-bowel diseases. Endoscopy (2007) 1.81
The clinical and endoscopic spectrum of the watermelon stomach. J Clin Gastroenterol (1992) 1.78
Dieulafoy's disease: endoscopic treatment and follow up. Gut (1993) 1.63
The watermelon stomach: long-term outcome in patients treated with Nd:YAG laser therapy. Gastrointest Endosc (1995) 1.63
Prevalence and factors influencing hemorrhoids, anorectal varices, and colopathy in patients with portal hypertension. Endoscopy (1996) 1.62
Gastric antral vascular ectasia in systemic sclerosis: demographics and disease predictors. J Rheumatol (2010) 1.62
Factors influencing development of portal hypertensive gastropathy in patients with portal hypertension. Gastroenterology (1992) 1.61
Prevalence of upper and lower gastrointestinal tract findings in liver transplant candidates undergoing screening endoscopic evaluation. Am J Gastroenterol (1999) 1.51
The effects of transjugular intrahepatic portosystemic shunt on portal hypertensive gastropathy. J Gastroenterol Hepatol (1998) 1.43
Angiographic findings and endovascular embolization in Dieulafoy disease: a case report and literature review. Diagn Interv Radiol (2006) 1.40
Frequency, significance and therapy of the Mallory-Weiss syndrome in patients with portal hypertension. Hepatology (1990) 1.39
Changes in characteristics and outcome of acute upper gastrointestinal haemorrhage: a comparison of epidemiology and practices between 1996 and 2000 in a multicentre French study. Eur J Gastroenterol Hepatol (2005) 1.36
A self-expanding metal stent for complicated variceal hemorrhage: experience at a single center. Gastrointest Endosc (2009) 1.35
Portal colopathy: prospective study of colonoscopy in patients with portal hypertension. Gastroenterology (1991) 1.33
Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology (2001) 1.29
Hemostasis of Dieulafoy's lesions by argon plasma coagulation (with video). Gastrointest Endosc (2007) 1.27
The role of propranolol in congestive gastropathy of portal hypertension. Hepatology (1987) 1.26
Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology (2000) 1.24
The Mallory-Weiss syndrome and lesion. A study of 30 cases. Am J Dig Dis (1966) 1.20
Transjugular intrahepatic portosystemic shunt for bleeding angiodysplasia-like lesions in portal-hypertensive colopathy. Gastroenterology (1998) 1.17
Mallory-Weiss syndrome. A study of 224 patients. Am J Surg (1983) 1.14
TIPS with expanded polytetrafluoroethylene-covered stent: results of an Italian multicenter study. AJR Am J Roentgenol (2005) 1.13
Endoscopic band ligation and endoscopic hemoclip placement for patients with Mallory-Weiss syndrome and active bleeding. World J Gastroenterol (2008) 1.13
The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Aliment Pharmacol Ther (1999) 1.12
Outcomes of endoscopic treatment of gastroduodenal Dieulafoy's lesion with rubber band ligation and thermal/injection therapy. J Clin Gastroenterol (2003) 1.11
Natural history of congestive gastropathy in cirrhosis. The Liver Study Group of V. Cervello Hospital. Gastroenterology (1990) 1.11
Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology (2000) 1.11
Successful control of bleeding from gastric antral vascular ectasia (watermelon stomach) by laser photocoagulation. Gut (1991) 1.09
Portal hypertensive colopathy. A new entity. Dig Dis Sci (1991) 1.08
Upper gastrointestinal haemorrhage in hepatic cirrhosis: causes and relation to hepatic failure and stress. Lancet (1977) 1.08
Colonic disease in cirrhosis. An endoscopic evaluation in 412 patients. Gastroenterology (1990) 1.07
Management of upper gastrointestinal bleeding in the patient with chronic liver disease. Med Clin North Am (1996) 1.07
Clinical significance of Mallory-Weiss tears. Am J Gastroenterol (1993) 1.05
Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis. J Hepatol (2000) 1.05
Gastric antral vascular ectasia: a case report and review of the literature. J Nucl Med (1996) 1.04
Prognosis after the first episode of gastrointestinal bleeding or coma in cirrhosis. Survival and prognostic factors. Scand J Gastroenterol (1989) 1.04
High prevalence of Helicobacter pylori in liver cirrhosis: relationship with clinical and endoscopic features and the risk of peptic ulcer. Dig Dis Sci (1997) 1.03
Bacterial infections in liver disease. Semin Liver Dis (1997) 1.02
The management of portal hypertensive gastropathy and gastric antral vascular ectasia. Dig Liver Dis (2010) 1.02
Exulceratio simplex as conceivable cause of massive gastric hemorrhage. Surg Gynecol Obstet (1982) 1.02
Long-term risk of recurrent peptic ulcer bleeding in patients with liver cirrhosis: a 10-year nationwide cohort study. Hepatology (2012) 1.01
Prevalence and natural history of gastric antral vascular ectasia in patients undergoing orthotopic liver transplantation. J Clin Gastroenterol (2004) 1.01
The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding. Am J Gastroenterol (1998) 1.01
Mallory-Weiss tear: predisposing factors and predictors of a complicated course. Am J Gastroenterol (2001) 1.01
Effect of portal hypertension in the small bowel: an endoscopic approach. Dig Dis Sci (2007) 1.00
Colonic mucosal changes in patients with liver cirrhosis. Gastrointest Endosc (1995) 1.00
A prospective, randomized trial of endoscopic band ligation vs. epinephrine injection for actively bleeding Mallory-Weiss syndrome. Gastrointest Endosc (2004) 0.98
Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with estrogen-progesterone in cirrhotic patients: an open pilot study. Am J Gastroenterol (1999) 0.98
Dieulafoy disease of the colon. Arch Pathol Lab Med (2009) 0.98
Clinical relevance of colonic lesions in cirrhotic patients with portal hypertension. Endoscopy (2006) 0.98
Bleeding from gastric antral vascular ectasia in marrow transplant patients. Gastrointest Endosc (1996) 0.97
The natural history of portal hypertensive gastropathy in patients with liver cirrhosis and mild portal hypertension. Am J Gastroenterol (2004) 0.97
Upper gastrointestinal bleeding in patients with hepatic cirrhosis: clinical course and mortality prediction. Am J Gastroenterol (2000) 0.97
Somatostatin for acute severe bleeding from portal hypertensive gastropathy. Eur J Gastroenterol Hepatol (1998) 0.96
Mallory-Weiss syndrome. A reappraisal. JAMA (1975) 0.96
Predicting failure to control bleeding and mortality in acute variceal bleeding. J Hepatol (2007) 0.96
Helicobacter pylori infection in patients with liver cirrhosis: facts and fictions. Dig Liver Dis (2003) 0.95
Comparison of the efficacy of octreotide, vasopressin, and omeprazole in the control of acute bleeding in patients with portal hypertensive gastropathy: a controlled study. J Gastroenterol Hepatol (2002) 0.94
Bleeding gastric vascular ectasia treated by argon plasma coagulation: a comparison between patients with and without cirrhosis. Gastrointest Endosc (2008) 0.94
Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trial. Am J Gastroenterol (2006) 0.93
Acute gastrointestinal bleeding from portal hypertensive gastropathy: prevalence and clinical features. Am J Gastroenterol (1993) 0.93
A 70-year-old man with episodes of upper gastrointestinal bleeding. Dieulafoy lesion/malformation. Arch Pathol Lab Med (2006) 0.93
Acute upper gastrointestinal bleeding in patients with liver cirrhosis and in noncirrhotic patients: epidemiology and predictive factors of mortality in a prospective multicenter population-based study. J Clin Gastroenterol (2005) 0.93
Caliber-persistent artery of the stomach (Dieulafoy's vascular malformation). Gastroenterology (1990) 0.93
Relationship of portal pressure, anorectal varices and hemorrhoids in cirrhotic patients. J Hepatol (1992) 0.93
Mallory-Weiss syndrome. Evolution of diagnostic and therapeutic patterns over two decades. Ann Surg (1980) 0.92
Mallory-Weiss syndrome. Characterization of 75 Mallory-weiss lacerations in 528 patients with upper gastrointestinal hemorrhage. Gastroenterology (1976) 0.91
Peptic ulceration in patients with chronic liver disease. Dig Dis Sci (1980) 0.91
Colonic disease in cirrhotic patients with portal hypertension: an endoscopic and clinical evaluation. J Clin Gastroenterol (1998) 0.91
Mucosal abnormalities of the colon in patients with portal hypertension: an endoscopic study. Gastrointest Endosc (2000) 0.91
Portal hypertensive colopathy in patients with liver cirrhosis. World J Gastroenterol (2005) 0.91
Peptic ulcer and its course in cirrhosis: an endoscopic and clinical prospective study. J Hepatol (1995) 0.91
Jejunal Dieulafoy lesion with massive lower intestinal bleeding. Int J Colorectal Dis (2006) 0.90
Tranexamic acid for severe bleeding gastric antral vascular ectasia in cirrhosis. Gut (1998) 0.90
Upper gastrointestinal bleeding in cirrhosis: clinical and endoscopic correlations. Gut (1976) 0.90
Portal hypertensive gastropathy in patients with cirrhosis. Gastroenterology (1992) 0.90
Gastric antral vascular ectasia successfully treated by endoscopic electrocoagulation. J Gastroenterol (1998) 0.89
Main causes of death in cirrhosis. Scand J Gastroenterol (1983) 0.88
Characteristic endoscopic features of portal hypertensive enteropathy. J Gastroenterol (2008) 0.88
[Clinical aspects and endoscopic management of gastrointestinal bleeding from Dieulafoy's lesion]. Rev Esp Enferm Dig (2007) 0.88
Cure of gastric antral vascular ectasia by liver transplantation despite persistent portal hypertension: a clue for pathogenesis. Liver Transpl (2002) 0.87
Effect of transjugular intrahepatic portosystemic shunt formation on portal hypertensive gastropathy and gastric circulation. Am J Gastroenterol (2001) 0.87
Nonvariceal upper gastrointestinal bleeding in patients with liver cirrhosis. Clinical features, outcomes and predictors of in-hospital mortality. A prospective study. Ann Hepatol (2011) 0.87
Bacterial infections in patients with cirrhosis. J Hepatol (1993) 0.87
Portal hypertensive colopathy in patients with cirrhosis. Scand J Gastroenterol (1996) 0.87
Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial. Lancet (2002) 3.68
Is pseudomembranous colitis infectious? Lancet (1981) 2.34
Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut (2007) 2.20
Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther (2006) 2.00
Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus, and administration of methylprednisolone as risk factors for HCMV disease following liver transplantation. J Infect Dis (1997) 1.77
Small hepatocellular carcinomas in cirrhotic explant livers: identification by macroscopic examination and lipiodol localization. Hepatology (1997) 1.48
Psychiatric and social outcome of liver transplantation. Br J Psychiatry (1995) 1.46
Infection, coagulation, and variceal bleeding in cirrhosis. Gut (2005) 1.39
Incidence, risk factors, management, and outcome of portal vein abnormalities at orthotopic liver transplantation. Transplantation (1994) 1.28
Public awareness of risk factors and screening for colorectal cancer in Europe. Eur J Cancer Prev (2004) 1.25
Polyfunctional cytomegalovirus-specific CD4+ and pp65 CD8+ T cells protect against high-level replication after liver transplantation. Am J Transplant (2008) 1.24
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther (2006) 1.15
Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies. J Viral Hepat (2008) 1.11
Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography. J Hepatol (1997) 1.10
Prospective study of hepatobiliary scintigraphy and endoscopic cholangiography for the detection of early biliary complications after orthotopic liver transplantation. Br J Surg (1997) 1.08
Improvement in renal function in hepatorenal syndrome with N-acetylcysteine. Lancet (1999) 1.07
Factors related to early mortality after transjugular intrahepatic portosystemic shunt for failed endoscopic therapy in acute variceal bleeding. J Hepatol (1998) 1.07
Hepatic venous pressure measurement: an old test as a new prognostic marker in cirrhosis? Hepatology (1997) 1.04
Evidence for intestinal oxidative stress in obstructive jaundice-induced gut barrier dysfunction in rats. Acta Physiol Scand (2004) 1.00
Predisposing factors and clinical symptoms in HIV-negative patients with Candida oesophagitis: are they always present? Int J Clin Pract (2005) 0.97
Improved survival of patients presenting with acute variceal bleeding. Prognostic indicators of short- and long-term mortality. Dig Liver Dis (2006) 0.96
Biliary anastomosis after liver transplantation does not benefit from T tube splintage. Transplantation (1994) 0.96
Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: long-term follow-up. Transplantation (2000) 0.96
Predicting failure to control bleeding and mortality in acute variceal bleeding. J Hepatol (2007) 0.96
Maximizing participation by black Americans in population-based diabetes research: the Project DIRECT pilot experience. J Community Health (1998) 0.96
Assessment of the agreement between wedge hepatic vein pressure and portal vein pressure in cirrhotic patients. Dig Liver Dis (2005) 0.94
Variceal bleeding and portal hypertensive gastropathy. Eur J Gastroenterol Hepatol (2001) 0.93
Hepatic sinusoidal endothelium: Ulex lectin binding. Histopathology (1989) 0.93
The effects of glycosaminoglycans on coagulation: a thromboelastographic study. Blood Coagul Fibrinolysis (2007) 0.92
Autoimmune cholangitis in a patient with celiac disease: a case report and review of the literature. J Hepatol (1999) 0.92
Adult "idiopathic" extrahepatic venous thrombosis. Importance of putative "latent" myeloproliferative disorders and comparison with cases with known etiology. Dig Dis Sci (1992) 0.92
Chronic ecstasy (3,4-methylenedioxymetamphetamine) abuse: a recurrent and unpredictable cause of severe acute hepatitis. J Hepatol (1996) 0.90
Management of portal hypertension. Postgrad Med J (2004) 0.90
Nature and standards of gastrointestinal and liver services in the United Kingdom. Gut (1993) 0.90
Results of choledochojejunostomy in the treatment of biliary complications after liver transplantation in the era of nonsurgical therapies. Liver Transpl (2000) 0.89
A simulation modelling approach to evaluating alternative policies for the management of the waiting list for liver transplantation. Health Care Manag Sci (2001) 0.89
Intraoperative use of aprotinin (Trasylol) in orthotopic liver transplantation. Transplant Proc (1991) 0.84
Review article: the therapeutic and prognostic benefit of portal pressure reduction in cirrhosis. Aliment Pharmacol Ther (2008) 0.83
Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis. Transpl Infect Dis (2006) 0.83
Impact of tips preliver transplantation for the outcome posttransplantation. Am J Transplant (2008) 0.83
Liver transplantation complicated by embedded transjugular intrahepatic portosystemic shunt: a new method for portal anastomosis- a surgical salvage procedure. Liver Transpl (2000) 0.83
Bacillus cereus induces permeability of an in vitro blood-retina barrier. Infect Immun (2008) 0.82
Budd-Chiari syndrome: blocked veins, open mind. Gut (1999) 0.81
Review article: pharmacological treatment of the hepatorenal syndrome in cirrhotic patients. Aliment Pharmacol Ther (2000) 0.80
Oesophageal transection for variceal bleeding. Lancet (1984) 0.79
Longterm follow-up of biliary stents for retained common bile duct stones in elderly patients. J R Coll Surg Edinb (1995) 0.79
Acute Budd-Chiari syndrome treated by liver transplantation in a woman homozygous for factor V Leiden. Eur J Gastroenterol Hepatol (1996) 0.78
Variceal and portal pressure measurement: techniques and applications. Ital J Gastroenterol (1996) 0.78
Meta-analysis: antiviral treatment for hepatitis D. Aliment Pharmacol Ther (2012) 0.78
Causes and clinical outcome of acute upper gastrointestinal bleeding: a prospective analysis of 1534 cases. Int J Clin Pract (2000) 0.77
Relief of biliary obstruction due to portal vein cavernoma using a transjugular intrahepatic portosystemic shunt (TIPS) without the need for long-term stenting. Endoscopy (2006) 0.76
Organ transplantation and discrimination. Patients with hepatitis B should not be given low priority. BMJ (2000) 0.76
Impact of aprotinin on blood transfusion requirements in liver transplantation. Transfus Med (1993) 0.76
Outcome of surgery for failed endoscopic extraction of common bile duct stones in elderly patients. Ann R Coll Surg Engl (1994) 0.76
Psychiatric and social outcome following liver transplantation for alcoholic liver disease: a controlled study. J Psychosom Res (1999) 0.76
Antituberculous therapy and acute liver failure. Lancet (1995) 0.76
Intravenous albumin in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med (1999) 0.75
Ursodeoxycholic acid in primary sclerosing cholangitis. Aliment Pharmacol Ther (2012) 0.75
Antiviral treatment after solid organ transplantation. Lancet (2005) 0.75
Octreotide followed by sclerotherapy was not more effective than emergency injection sclerotherapy for acute variceal haemorrhage. Gut (1998) 0.75
Octreotide for cirrhosis after variceal bleeding. Authors' claims for octreotide were not justified. BMJ (1998) 0.75
Measurement of O6-methylguanine-type adducts in DNA and O6-alkylguanine-DNA-alkyltransferase repair activity in normal and neoplastic human tissues. Comp Biochem Physiol B (1992) 0.75
Management of oesophageal varices. Hosp Med (2000) 0.75
Emergency endoscopy in upper gastrointestinal haemorrhage: evaluation of 885 patients. J R Coll Surg Edinb (1988) 0.75
Obstructive jaundice secondary to neuroendocrine tumour in a patient with von Recklinghausen's disease. Eur J Gastroenterol Hepatol (2005) 0.75
Effect of reperfusion on human allograft ICAM-1 expression and its correlation with histological evidence of reperfusion changes. Transplant Proc (1997) 0.75
Drug treatment for bleeding oesophageal varices. Baillieres Best Pract Res Clin Gastroenterol (2000) 0.75
Patients with gastroesophageal reflux disease and respiratory manifestations do not present lung function disorders during cardiopulmonary exercise test. Dis Esophagus (2010) 0.75
Portal hypertension and hepatic sinusoidal Ulex lectin binding. J Hepatol (1990) 0.75
Outcome of diabetic pregnancies in Waikato: five year experience. N Z Med J (1985) 0.75
Six-month maintenance treatment of duodenal ulcer with sucralfate: influence on antral gastritis and Helicobacter pylori antral colonization--a prospective uncontrolled study. Clin Ther (1993) 0.75
Research. Nursing measures to improve birth and early mothering for adolescents. ANA Publ (1984) 0.75
Primary herpes simplex virus type-2 infection as a cause of liver failure after liver transplantation. Transpl Infect Dis (2006) 0.75
Hospice thoughts. Nurs Times (1989) 0.75
Haemorrhagic-erosive gastritis, a study of 350 endoscopically identified cases. Br J Clin Pract (1988) 0.75